Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Lymphoma 1

Interventions

Cyclophosphamide 344Rituximab 307Vincristine 159Doxorubicin 156venetoclax 154Specimen Handling 154fludarabine 153Prednisone 151Biopsy 124Magnetic Resonance Spectroscopy 119obinutuzumab 116Lenalidomide 110Dexamethasone 105Cytarabine 98ibrutinib 96Etoposide 92fludarabine phosphate 87Methotrexate 85acalabrutinib 78Bendamustine Hydrochloride 73zanubrutinib 72blinatumomab 64pembrolizumab 62CT-P10 60Gemcitabine 51Nivolumab 45Calcium Dobesilate 45glofitamab 44Mercaptopurine 44prednylidene 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
crenigacestat × Lymphoid × 1 year × Clear all
NCT01695005 2025-12-26

A Study of LY3039478 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
247 enrolled 53 charts
Lymphoid

Lymphoma, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡